Repeal campaigns stall in Arizona as Idaho medical cannabis activists oversubscribe their ballot push, fresh research on legalisation arrests lands, and the industry’s medical-marketing claims and Tilray’s expansion playbook draw scrutiny.
Reclassification confusion, an IPO revival in cannabis pharma and a contentious DEA registration form dominate today’s cannabis news, alongside fresh European consolidation and a return of investor focus on the sector’s ETFs.
Reform momentum builds on both sides of the Atlantic as Richard Branson presses for UK cannabis change, Indiana’s governor signals openness to legalisation, and analysts map the banking access unlocked by US rescheduling.
Today’s cannabis briefing covers the fallout from the US Justice Department’s Schedule III order, fresh travel guidance for UK medical patients, California’s ten-year legalisation milestone, environmental scrutiny at a Trulieve mega-grow, and a notable state-level legalisation recommendation in North Carolina.
